Peter Schäfer
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments 50
- Immunology top 1%
- Immune Cell Function and Interaction 13
- Mast cells and histamine 11
- Oncology top 1%
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 15
- Molecular Biology top 1%
- Protein Degradation and Inhibitors 35
- Ubiquitin and proteasome pathways 16
- Phosphodiesterase function and regulation 12
-
- Hepatitis C virus research 11
- Co-authors
- George W. MullerDavid StirlingMiles D. HouslayKam Y. J. ZhangRajesh ChopraJ. Blake BartlettBernd FinkRainer Laufs
- Cited by
- HematologyImmunologyOncology
- Journals
- Blood (26 papers)Journal of Clinical Microbiology (10 papers)Annals of the Rheumatic Diseases (10 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Peter Schäfer
200 papers receiving 10.5k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Hematology 2.9k
- Immunology 2.3k
- Oncology 2.6k
- Genetics 941
- Molecular Biology 4.7k
Countries citing papers authored by Peter Schäfer
This map shows the geographic impact of Peter Schäfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schäfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schäfer more than expected).
Fields of papers citing papers by Peter Schäfer
This network shows the impact of papers produced by Peter Schäfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schäfer. The network helps show where Peter Schäfer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Schäfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2021 | 2 | |
| 5 | 2019 | 18 | |
| 6 | 2019 | 45 | |
| 7 | 2017 | 2 | |
| 8 | Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate | 2013 | 457 |
| 9 | 2012 | 6 | |
| 10 | VEGFr inhibitor YN968D1 xenograft dose response studies against human colon cancer Ls174t and HT29 | 2006 | 13 |
| 11 | 2006 | 142 | |
| 12 | 2005 | 40 | |
| 13 | A novel PDE4 inhibitory agent with endothelial cell specific activity. | 2004 | 1 |
| 14 | A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins. | 2003 | 45 |
| 15 | 2003 | 21 | |
| 16 | 2002 | 10 | |
| 17 | 2001 | 4 | |
| 18 | Vanillingehalte und Inhaltsstoff-Verhältniszahlen von Vanilleschoten : Einfluss der Extraktionsbedingungen auf die ermittelten Werte : Diskussion von Richtwerten | 1999 | 1 |
| 19 | 1994 | 47 | |
| 20 | 1991 | 101 |
About Peter Schäfer
Peter Schäfer is a scholar working on Hematology, Immunology and Hepatology, having authored 209 papers that have together received 10.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (50 papers), Protein Degradation and Inhibitors (35 papers), Ubiquitin and proteasome pathways (16 papers), Chronic Lymphocytic Leukemia Research (15 papers), Immune Cell Function and Interaction (13 papers), Phosphodiesterase function and regulation (12 papers), Mast cells and histamine (11 papers) and Hepatitis C virus research (11 papers). The work is most often cited by research in Hematology (2.9k citations), Immunology (2.3k citations) and Oncology (2.6k citations). Peter Schäfer has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include George W. Muller, David Stirling, Miles D. Houslay, Kam Y. J. Zhang, Rajesh Chopra, J. Blake Bartlett, Bernd Fink, Rainer Laufs, Lei Wu and Anita K. Gandhi. Their work appears in journals such as Blood, Journal of Clinical Microbiology, Annals of the Rheumatic Diseases, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.